Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427
Clinical trial NCT04475198 · TERMINATED
Trial details
- NCT number
- NCT04475198
- Sponsor
- SiteOne Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2021-08-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.